Cosmetic surgery market predicted to double by 2017

The market for cosmetic surgery, facial aesthetics and lasers is expected to almost double in size and to exceed $3 billion over the next seven years, according to iData Research, a pharmaceutical market research firm based in Vancouver, British Columbia, PRNewswire reports.The iData report estimates that the market for aesthetic botulinum toxin A drugs such as Botox (onabotulinumtoxinA, Allergan) will grow to an estimated $543 million by 2017, and that the aesthetic laser and light therapy markets for skin resurfacing, hair removal and laser lipolysis are the fastest-growing segments.

The U.S. market for aesthetic facial injectable products is valued at nearly $860 million now, according to the report. It adds that use of botulinum toxin is likely to increase due to the expected introduction of PurTox (Mentor), and also to a growing number of therapeutic possibilities. Read more

Sound Surgical Technologies Introduces VASER® SHAPE MC1™

Sound Surgical Technologies, a leading manufacturer and distributor of ultrasonic body contouring technologies, announced the launch of VASER Shape MC1 today, a non-invasive ultrasound and massage system. Most well-known for the VASER Lipo® System, Sound Surgical Technologies has expanded its product line to include both minimally invasive devices for aesthetic body contouring and non-invasive systems to smooth and shape the body by temporarily reducing the appearance of cellulite and increasing local blood circulation.

“The VASER Lipo System has revolutionized the way surgeons approach fat removal, and we’re excited to add an effective non-invasive tool to the VASER product line,” said Daniel S. Goldberger, CEO of Sound Surgical Technologies.

VASER Shape MC1 received FDA clearance in May 2010 for relief of minor muscle aches, pain and muscle spasms, temporary improvement in local blood circulation, and temporary reduction in the appearance of cellulite. VASER Shape can be used alone or in combination with surgical body contouring procedures to minimize postoperative pain and swelling. The VASER Shape MC1 device is derived from a technology known as MedContour™ outside of the US, which has been used by hundreds of physicians to achieve excellent results.

“This new technology is the perfect complement for existing body contouring and liposuction procedures,” said Dr. Paul Zieg, Board Certified Plastic Surgeon at Zieg Plastic Surgery Center in Henderson, KY. “The VASER Shape MC1 System allows physicians to target specific problem areas for maximum results, while leaving the surrounding tissues unaffected.” Read more

IAPAM Launches new “Ask an Expert hCG Questions” Website for Members

In support of providing ongoing education to IAPAM members, and particularly to members who have completed the IAPAM’s hCG Medical Weight Management Training, the IAPAM has launched a new web-page showcasing critical questions and expert answers for physicians who are implementing the exclusive IAPAM hCG Protocol.

From questions regarding managing cravings to inquiries about vegetarian options for hCG patients, the IAPAM’s new “Ask an Expert hCG Questions” resource page offers IAPAM members usable intelligence on hCG as part of a Medical Weight Management Program.  The new Ask an Expert hCG Questions page provides physicians with an additional resource to use during the implementation phase of a new Medical Weight Management Program.

The IAPAM’s hCG Physician Medical Weight Management training gives doctors “everything they need to start offering medical weight loss programs to their patients immediately upon returning to their practices,” emphasizes Jeff Russell, Executive Director of the IAPAM, and one of the IAPAM faculty instructors presenting at the IAPAM’s hCG training.  Now, physicians or patients with questions about hCG, or the administration of an hCG protocol, can “ask the experts” their questions, and find the answers on the IAPAM’s Ask an Expert hCG Questions page. Read more

Plastic Surgeons to Discuss “Cold Botox,” Cellulite Busters and Other Hot Topics with the Media

The American Society of Plastic Surgeons (ASPS) is bringing its popular Hot Topics in Plastic Surgery panel directly to journalists during a Hot Topics Overview/Webinar for the Media. During this dynamic hour, journalists can get answers to questions on emerging procedures, trends, and new technologies while engaging in conversation with the experts. Journalists can participate onsite in Toronto or via webinar. The webinar format is entirely Q&A.

What: The American Society of Plastic Surgeons (ASPS) is bringing its popular Hot Topics in Plastic Surgery panel directly to journalists during a Hot Topics Overview/Webinar for the Media. During this dynamic hour, journalists can get answers to questions on emerging procedures, trends, and new technologies while engaging in conversation with the experts. Journalists can participate onsite in Toronto or via webinar. The webinar format is entirely Q&A. Read more

New TotalFX Reduces Signs of Aging in a Single Treatment

Laser Cliniqúe, San Diego’s premier medical spa, introduces TotalFX, the latest non-invasive technology for reducing the signs of aging.

Millions of Americans seek relief from the signs of an aging complexion, which includes fine lines, wrinkles, enlarged pores, age spots, sun spots and uneven skin tone and texture. Laser Cliniqúe, San Diego’s premier medical spa, is proud to offer TotalFX fractional laser resurfacing technique. This procedure is the latest treatment for painlessly and efficiently eliminating the signs of aging.

For today’s more active population, the prolonged healing time involved with conventional laser or face-lift surgery is not appropriate. Dr. P. Alexander Ataii, Medical Director of Laser Cliniqúe, offers TotalFX for patients seeking a less-invasive, highly-effective skin rejuvenation procedure because it treats fine lines, pigmentation, enlarged pores, age spots and uneven skin tones in a single treatment. Patients typically only experience five to seven days of downtime. TotalFX also helps scarring, such as deep pitted acne scars, due to the increase of collagen stimulation with this treatment.

The treatment does more than soften the appearance of imperfections; it can actually eliminate evidence of sun damage and aging, providing a comprehensive and long-lasting solution. In fact, improvement continues long after treatment. In the months following treatment, new collagen is generated deep in the skin, plumping it, improving its elasticity and continuing the improvement of the texture of the skin.

During the procedure, a high-energy beam of laser light is used to smooth out lines, wrinkles and scars, and remove dark sun spots and other irregularities, layer by layer. The Encore Ultrapulse CO2 laser that performs the procedure is a proven gold standard laser in skin rejuvenation that tightens skin and leads to collagen and elastin production.

For more information on TotalFX and other anti-aging treatments, please visit Laser Cliniqúe’s website at http://www.laser-clinique.com or call 858-481-7701.

Cosmetic Surgery, Botox(R) and Aesthetic Laser Markets to Grow to Over $3 Billion in the U.S.

New Botulinum Toxin Drugs Enter the Market, Ending Allergan’s Monopoly.

According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, the market for cosmetic surgery, facial aesthetics and medical lasers is expected to almost double in size, exceeding $3 billion by 2017. The market for aesthetic Botulinum toxin-A drugs such as Botox(R) will grow to an estimated $543 million by 2017, while the aesthetic laser and light therapy markets for skin resurfacing, hair removal and laser lipolysis are the fastest growing segments.

“Allergan has had a monopoly on Botulinum toxin A drugs since 2002, but now faces competition from Dysport(R) by Medicis as well as other new competitors expected to enter the market,” says Dr. Kamran Zamanian, CEO of iData. “Allergan and Medicis have been fierce rivals, as their Juvederm(R) and Restylane(R) facial dermal fillers compete in the lucrative dermal filler market.” Read more

Lippincott Williams & Wilkins Signs Licensing Agreement with Chinese Journal of Aesthetic and Plastic Surgery to Share Content with Plastic and Reconstructive Surgery

Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, is pleased to announce that it has entered into a licensing agreement with the Chinese Journal of Aesthetic and Plastic Surgery (CJAPS), to provide selected articles and abstracts from Plastic and Reconstructive Surgery (PRS), the official journal of the American Society of Plastic Surgeons, to be translated into Chinese and published in CJAPS. LWW is the publisher of record for PRS.

Karen Abramson, President and CEO, Wolters Kluwer Health Medical Research, will join CJAPS at a signing ceremony in Shenyang, China on September 14th attended by leading Chinese plastic & reconstructive surgery specialists, along with representatives from CJAPS, PRS, and Wolters Kluwer. Key attendees include Dr. Jingheng Gao, Editor-in-Chief of CJAPS, Dr. Rod Rohrich, MD, Editor-in-Chief of PRS, and Dr. Zhanquan Li, Vice President of The People’s Hospital of Liaoning Province (Sponsor of CJAPS). Dr. Rohrich also will give an academic presentation following the ceremony.

CJAPS will feature PRS full text articles in Chinese and English abstracts in a special section of the journal on a bi-monthly basis.

“This agreement with CJAPS demonstrates our dedication to expanding access to leading health and medical research in China –- and throughout the world,” said Abramson. “Our publishing initiatives are grounded in helping society partners uncover new distribution and online content channels — sharing important and relevant published content from one esteemed journal to the other. This partnership agreement is an ideal fit for CJAPS and PRS.” Read more

Next Page »